Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omeprazole Dosing in Non-Variceal Upper GI Bleeding
NCT03980496Phase 4Completed
- Sponsor
- Medical University of Białystok
- Start
- Sep 2010
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of omeprazole in non-variceal upper gastrointestinal bleeding (NVUGIB) (2 arms), sponsored by Medical University of Białystok. Primary endpoints: Intragastric pH percentage of time >4.0 and >6.0 at 72 hours, Intragastric pH at specified time after initial bolus at 72 hours and 2 more. Started Sep 2010; status: completed.
02
Drugs
omeprazole
03
Conditions
non-variceal upper gastrointestinal bleeding (NVUGIB)
Beyond the preview
Go deeper on NCT03980496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03980496.